Dear Stakeholder, These are challenging times. To me, there is no doubt that humankind will triumph. In doing so, it will show its resiliency, fortitude, and kindness in each of us. As a diagnostic provider, we are currently working with the US federal agencies and our global partner companies to see how our capabilities and expertise may...Read more
Recent Posts by DMI
Invention enables manipulation of small blood samples for accurate point-of-care diagnosis BEDFORD, Mass., January 5, 2020 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., announced today the issuance of United States Patent Number 10,449,537 titled “Capillary manipulation of clinical samples.” The patent describes a system for collection and delivery of minute blood samples to...Read more
“We are very pleased to be invited by WFH to present our FVIII solution for home and in-office measurement of FVIII levels. Our approach provides a high-level of accuracy for FVIII measurements, particularly for long-acting and gene therapy-based FVIII therapies where conventional testing via activated partial thromboplastin time is less appropriate,” said Eugene Y. Chan,...Read more
Blood analyzers to be qualified for spaceflight by NASA’s Commercial-Off-The Shelf (COTS) certification process CAMBRIDGE, Mass., September 30, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that rHEALTH ONE blood analyzers have been delivered to NASA and its prime contractor Zin Technologies for spaceflight qualification. The technology will undergo a rigorous...Read more
rHEALTH tests to be presented at the industry’s leading annual conference for laboratory medicine CAMBRIDGE, Mass., July 11, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that both of its abstracts have been accepted via peer-review from for the 2019 American Association of Clinical Chemistry (AACC) meeting. The titles and details...Read more
Recent Comments by DMI
No comments by DMI yet.